...
CIPM 2026 Q&A cover: pellet and 3-in-1 granulation at JIANPAI booth
CIPM 2026 Soru-Cevap: Santrifüj Granülasyon ve Ekstrüzyon ile 3’ü 1 Arada Granülatör
From October 27 to 29, 2026, the 68th China National Pharmaceutical Machinery Expo (CIPM 2026) filled...
CIPM 2026 Q&A cover: smart OSD, mixing and coating at JIANPAI booth 2-B27
CIPM 2026 Soru-Cevap: Akıllı OSD Üretimi, Üçlü Eksantrik Karıştırma ve Kaplama
At CIPM 2026 in Xiamen (October 27-29, 2026), visitors to JIANPAI Booth 2-B27 did not ask for brochures....
JianPai Technology team at CIPM 2026 Xiamen
JianPai Technology, CIPM 2026 Xiamen Katılımını Başarıyla Tamamladı
JianPai Technology wraps up CIPM 2026 Xiamen at Booth 2-B27 (Oct 27–29): fluid bed and high-shear granulators,...
Top generic pharma manufacturing companies in Indonesia 2026 B2B shortlist cover with JIANPAI fluid bed equipment
Endonezya’nın Önde Gelen Jenerik İlaç Üreticileri: 2026 B2B Alıcı Kısa Listesi
Indonesia’s generics market is shaped by BPOM licensing, CPOB (GMP) expectations, and JKN / e-catalogue...

HAKKIMIZDA

Hakkımızda - ekibimizi tanıtmak,
görev ve değerler.

2026 Dünyanın En Büyük 50 İlaç Şirketi (2025 Satış)

2026 Dünyanın En Büyük 50 İlaç Şirketi (2025 Satış)

The global pharmaceutical industry continues to experience strong growth driven by innovation in biologics, oncology, diabetes and obesity treatment, vaccines, and rare disease therapies. In August 2026, Pharm Exec magazine published the 2026 Pharm Exec 50, ranking the Top 50 pharmaceutical companies worldwide by prescription drug (Rx) sales in fiscal year 2025.

This ranking is widely regarded as one of the most authoritative industry benchmarks, offering valuable insight for pharmaceutical manufacturers, API and packaging suppliers, pharmaceutical equipment companies, and distributors and contract manufacturing organizations (CMOs).

Below is the fully updated 2026 Global Top 50 Pharmaceutical Companies List, based on 2025 Rx sales.

Sıralama Metodolojisi

  • Sıralama Kaynağı: Pharm Exec magazine (2026 Pharm Exec 50, published August 14, 2026)
  • Sıralama Esası: Global prescription drug (Rx) sales
  • Mali Yıl: 2025
  • Sıralama Yayınlanma Yılı: 2026

Bu sıralama yansıtıyor gerçek ticari performans, not market capitalization or valuation. Figures in the table are 2025 Rx sales, shown in US$ billion.

2026 Global Top 50 Pharmaceutical Companies (Complete List)

Rütbe Şirket Karargah 2025 Rx sales (US$ billion)
1 Eli Lilly Amerika 60.78
2 Johnson & Johnson Amerika 59.33
3 AbbVie Amerika 58.27
4 Roche İsviçre 57.51
5 AstraZeneca İngiltere 55.04
6 Merck & Co. (MSD) Amerika 54.69
7 Novartis'in İsviçre 54.33
8 Pfizer Amerika 49.91
9 Sanofi Fransa 48.97
10 Bristol-Myers Squibb Amerika 47.75
11 Novo Nordisk Danimarka 46.80
12 GSK (GlaxoSmithKline) İngiltere 42.72
13 Amgen Amerika 34.95
14 Takeda Japonya 29.67
15 Gilead Bilimleri Amerika 28.83
16 Boehringer Ingelheim Almanya 23.82
17 Bayer Almanya 19.19
18 CSL Avustralya 15.44
19 Viatris Amerika 14.09
20 Teva İsrail 14.08
21 Astella'lar Japonya 12.60
22 Daiichi Sankyo Japonya 12.04
23 Vertex İlaç Amerika 11.97
24 Sandoz Grubu İsviçre 11.09
25 Otsuka Holdings Japonya 9.87
26 Merck KGaA Almanya 9.73
27 UCB Belçika 8.24
28 Grifoller İspanya 7.33
29 Biyojen Amerika 7.12
30 Güneş Eczanesi Hindistan 6.44
31 Yenilenme Amerika 6.31
32 Organon Amerika 6.06
33 Yunnan Baiyao Çin 5.72
34 Abbott Amerika 5.51
35 Sunucu Fransa 5.44
36 Bausch Health Kanada 5.41
37 BeOne Medicines (formerly BeiGene) İsviçre 5.28
38 Fresenius Almanya 5.21
39 Shanghai Pharmaceuticals Çin 5.16
40 Eisai Japonya 4.78
41 Sino Biopharmaceutical Hong Kong 4.37
42 Menarini İtalya 4.36
43 kışkırt Amerika 4.35
44 İpsen Fransa 4.16
45 argenx Hollanda 4.15
46 Caz İlaçları İrlanda 4.02
47 STADA Almanya 4.02
48 Huadong Tıbbı Çin 3.97
49 Jiangsu Hengrui Tıp Çin 3.85
50 Haleon İngiltere 3.60

Data source: Pharm Exec, 2026 Pharm Exec 50 (FY 2025 prescription drug sales). Company names use common English forms; BeOne Medicines appears under its current name (formerly BeiGene).

Key Industry Trends from the 2026 Ranking

1. Eli Lilly Rises to No. 1

The headline change this year is Eli Lilly’s jump from No. 11 in the previous ranking to No. 1, with about $60.8 billion in 2025 Rx sales, up roughly 49% year over year. Johnson & Johnson, last year’s leader, is now No. 2. AbbVie, Roche, and AstraZeneca complete the top five.

2. U.S. Companies Continue to Lead by Count

Fifteen companies in the Top 50 are headquartered in the United States, still the largest national group, with particular strength in oncology, immunology, biologics, and metabolic disease, including GLP-1 therapies.

3. Switzerland, Japan, and Germany Remain Innovation Hubs

Switzerland is represented by Roche, Novartis, Sandoz, and BeOne Medicines (formerly BeiGene, now listed with a Swiss headquarters). Japan remains well represented by Takeda, Astellas, Daiichi Sankyo, Otsuka, and Eisai. Germany includes Boehringer Ingelheim, Bayer, Merck KGaA, Fresenius, and STADA.

4. China Holds Five Places; India Is Represented by Sun Pharma

Five Chinese companies are in this year’s list if Sino Biopharmaceutical (Hong Kong) is included: Yunnan Baiyao, Shanghai Pharmaceuticals (a new entrant), Sino Biopharmaceutical, Huadong Medicine, and Jiangsu Hengrui Medicine. CSPC Pharmaceutical Group is no longer in the Top 50. From India, Sun Pharma remains on the list; Dr. Reddy’s Laboratories is not in this year’s Top 50. New global entrants also include argenx (Netherlands) and Haleon (UK).

Bu Sıralama İlaç Tedarikçileri İçin Neden Önemli?

If you are involved in pharmaceutical machinery manufacturing, packaging solutions (vials, bottles, blister, ampoules), API and excipient supply, or contract manufacturing (CDMO/CMO), this list directly reflects where purchasing power is concentrated, which companies control global drug production, and who your most valuable long-term customers may be.

Outlook for the Global Pharmaceutical Industry in 2026

Based on this ranking, the pharmaceutical industry will continue focusing on biologics and biosimilars, GLP-1 diabetes and obesity drugs, cancer immunotherapy, rare disease treatments, and personalized medicine. Companies at the top of the 2026 Pharm Exec 50 are expected to drive mergers and acquisitions, equipment upgrades, and new plant investments worldwide.

Hangi ekipmanları kullanıyorsun?

Most companies in this ranking run large oral solid dosage (OSD) operations alongside biologics. Their tablet and capsule plants are built around a similar process chain, and each step needs GMP-grade equipment that produces repeatable batches. We cover this in detail in küresel ilk 50 ilaç şirketinin kaliteyi sağlamak için hangi ekipmanı kullandığı.

Proses Basamağı Amaç Related JIANPAI equipment
Islak granülasyon Bu kanal devlete bağlı olup akış ve içerik açısından eğitimcilere bırakılmıştır. Yüksek Kayma Yüksek Sıcaklık Viskozite Ölçümü (JHZ-C, JHZ-D)
Kurutma Granül nemini onaylanmış seviyeye düşürün. Akışkan yataklı kurutucular (JFG-C)
Boyutlandırma ve frezeleme Karıştırmadan önce partikül boyutunu kontrol edin İlaç fabrikaları (JZL boyutlandırma granülatörü)
Karıştırma Yağlar ve katkı maddeleri ecza (JPH üç eksantrikli karıştırıcı)
Kaplama Tabletlerin film, şeker veya enterik kaplaması Tablet kaplama makineleri (D -, -E-)
Entegre hatlar Elle taşımayı azaltan kapalı, bağlantılı granülasyon hatları Tamamen kapalı granülasyon üretim hattı, sürekli üretim

Bu liderleri tedarik eden veya onlarla rekabet eden jenerik ve sözleşmeli üreticiler, genellikle kendi hatlarını aynı standartlara göre kıyaslarlar. Bütçe planlaması için bkz. Tablet kaplama:.

Çözüm

. 2026 Global Top 50 Pharmaceutical Companies Ranking provides a clear overview of the world’s leading drug manufacturers, based on 2025 prescription drug sales, and reflects the direction of the global pharmaceutical industry. From biologics and oncology to diabetes, obesity, and rare disease therapies, these top companies will continue to drive innovation, capacity expansion, and equipment upgrades worldwide.

Profesyonel bir farmasötik makine üreticisi olarak, Jianpai closely follows the development trends of these global pharma leaders and is committed to providing reliable, high-efficiency production and processing solutions for pharmaceutical manufacturers across the world. Whether you are planning a new production line, upgrading existing equipment, or expanding your formulation and packaging capacity, JIANPAI offers customized solutions to meet your exact needs.

SSS

Who is the largest pharmaceutical company in the 2026 ranking?

Eli Lilly is No. 1 in the 2026 Pharm Exec 50, with about $60.8 billion in 2025 prescription (Rx) drug sales. Johnson & Johnson is No. 2. The complete Top 50 table above ranks companies by 2025 Rx sales, as described in the methodology section.

What equipment do top pharmaceutical companies use for oral solid dosage?

Large OSD plants typically run high shear wet granulation, fluid bed drying, milling and sizing, blending, tablet compression, and film or functional coating, often with closed material transfer and automated cleaning.

Why does this ranking matter for equipment suppliers?

Top companies set the quality and compliance expectations that generic and contract manufacturers follow. Equipment that meets their GMP, data integrity and containment needs is increasingly expected across the industry.

Bana göre Hırvat televizyonu, küresel standartlara bizden daha yakın.

JIANPAI, oral katı dozaj tesisleri için granülasyon, kurutma, öğütme, harmanlama ve kaplama ekipmanları tedarik etmektedir. Hat teklifi için ürünlerinizi ve hedef kapasitenizi bize gönderin.

E-posta: [email protected] | Telefon: +86 577-86932456 | No. 989 Lingde Yolu, Oujiangkou Yeni Bölgesi, Wenzhou, Zhejiang, Çin

tr_TRTR

Bize söyle Gereksinim Soru İhtiyaç Fikir Planlar